苏迎盈
医学博士，助理教授
厦门大学公共卫生学院
国家传染病诊断试剂与疫苗工程技术研究中心

Email：yingyingsu@xmu.edu.cn


工作经历：
2017.10―至今 厦门大学公共卫生学院 助理教授
2015.07―2017.08 厦门大学公共卫生学院 博士后


教育经历：
2013.09―2015.07 中国疾病预防控制中心，博士
2010.09―2013.07 中国疾病预防控制中心，硕士
2004.09―2008.07 武汉大学，学士



讲授课程：
《流行病学》《高级流行病学》《社会与健康》《预防医学》《循证医学》等。
研究方向：
疫苗临床试验和传染病的流行病学研究，包括:人乳头瘤病毒（HPV）的临床研究及相关流行病学研究；戊型肝炎病毒相关流行病学研究；巨细胞病毒母婴传播风险研究。主持国家自然科学基金面上项目、青年项目各1项，福建省自然科学基金面上项目1项，中国博士后科学基金面上项目1项。


代表性论文：
[1]Su YY, Zhang SY, Li TD, Xia NS. Early diagnosis and population prevention of coronavirus disease 2019. Curr Opin HIV AIDS 2020, 15(6): 345-50 (IF: 3.722).
[2]Wei FX^(#), Su YY^(#), Cui XL, Yu XJ, Li YF, Song QQ, Yin K, Huang SJ, Li MQ, Zhang J, Wu T*, Xia N. Sequential Acquisition of Human Papillomavirus Infection at Genital and Anal Sites, Liuzhou, China. Emerg Infect Dis. 2020, 26(10):2387-2393 (共一作者, IF: 6.259)
[3] Li W^(#), Su Y-Y^(#), Zhi S-S^(#), Huang J, Zhuang C-L, Bai W-Z, Wan Y, Meng X-R, Zhang L, Zhou Y-B, Luo Y-Y, Ge S-X^(*), Chen Y-K^(*), Ma Y^(*), Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2, Clin Microbiol Infect. 2020, 26(11):1556.e1-1556.e6. (共一作者，IF=7.117)
[4] Bin Lou^(#), Ting-Dong Li^(#), Shu-Fa Zheng^(#), Ying-Ying Su^(#), Zhi-Yong Li, Wei Liu, Fei Yu, Sheng-Xiang Ge^(*), Qian-Da Zou, Quan Yuan, Sha Lin, Cong-Ming Hong, Xiang-Yang Yao, Xue-Jie Zhang, Ding-Hui Wu, Guo-Liang Zhou, Wang-Heng Hou, Ting-Ting Li, Ya-Li Zhang, Shi-Yin Zhang, Jian Fan^(*), Jun Zhang^(*), Ning-Shao Xia, Yu Chen^(*). Serology characteristics of SARS-CoV-2 infection since exposure and post symptom onset. Eur Respir J. 2020, 56(2):**. (共一作者). (IF=12.339)
[5] Hong-Jun Zhang^(#) , Ying-Ying Su^(#) , Shi-Lin Xu^(#) , Guo-Qing Chen, Chang-Cheng Li, Ren-Jie Jiang, Rong-Hai Liu, Sheng-Xiang Ge^(*), Jun Zhang, Ning-Shao Xia, Tang Quan^(*). Asymptomatic and Symptomatic SARS-CoV-2 Infections in Close Contacts of COVID-19 Patients: A Seroepidemiological Study. Clin Infect Dis, 2020. doi: 10.1093/cid/ciaa771 (共一作者). (IF= 8.313)
[6] Juanjuan Zhao^(#), Quan Yuan^(#), Haiyan Wang ^(#),Wei Liu^(#), Xuejiao Liao^(#), Yingying Su^(#), Xin Wang, Jing Yuan, Tingdong Li, Jinxiu Li, Shen Qian, Congming Hong, Fuxiang Wang, Yingxia Liu, Zhaoqin Wang, Qing He, Zhiyong Li, Bin He, Tianying Zhang, Yang Fu, Shengxiang Ge^(*), Lei Liu^(*) , Jun Zhang^(*), Ningshao Xia, Zheng Zhang^(*). Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020, 71(16):2027-2034. (共一作者). (IF= 8.313)
[7] Lihui Wei^(#), Yingying Su^(#), Yuemei Hu, Rongcheng Li, Wen Chen, Qinjing Pan, Xun Zhang, Fanghui Zhao, Yuqian Zhao, Qing Li, Ying Hong, Chao Zhao, Mingqiang Li, Wenyu Liu, Caihong Li, Dongping Guo, Lidong Ke, Bizhen Lin, Zhijie Lin, Shu Chen, Wei Sheng, Zizheng Zheng, Sijie Zhuang, Fengcai Zhu, Huirong Pan, Yimin Li, Shoujie Huang, Jun Zhang(*), Youlin Qiao(*), Ting Wu(*), Ningshao Xia. Age distribution of human papillomavirus infection and neutralizing antibodies in healthy Chinese women aged 18-45 years enrolled in a clinical trial. Clin Microbiol Infect. 2020, 26(8):1069-1075. (共一作者). (IF= 7.117 )
[8] Ying-Ying Su^(#), Bi-Zhen Lin^(#), Hui Zhao, Juan Li, Zhi-Jie Lin, You-Lin Qiao, Li-Hui Wei, Yue-Mei Hu, Rong-Cheng Li, Si-Jie Zhuang, Guang Sun, Zi-Zheng Zheng, Shou-Jie Huang, Ting Wu(*), Jun Zhang, Hui-Rong Pan(*) & Chang-Gui Li (*). Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial, Hum Vaccin Immunother. 2020, 16(7):1636-1644. (IF= 2.619)
[9] Yingying Su^(#), Feixue Wei^(#), Xiumin Huang, Yafei Li, Lingxian Qiu, Fangfang Hu, Chaoqi Yang, Yuejing Zhang, Kai Yin, Mingqiang Li, Ting Wu(*), Ningshao Xia, Jun Zhang(*).Prevalence, concordance and transmission of human papillomavirus infection among heterosexual couples in Liuzhou, China: an observational perspective study. J Infect Dis, 2019;220:980–9 (IF= 5.022)
[10] Y-Y Su^(#); S-J Huang^(#); M Guo; J Zhao; H Yu; W-G He; H-M Jiang; Y-J Wang; X-F Zhang; J-P Cai; C-L Yang; Z-Z Wang; F-C Zhu; T Wu^(*); J Zhang^(*); N-S Xia, Persistence of antibodies acquired by natural hepatitis E virus infection and effects of vaccination. Clin Microbiol Infect, 2017, 23(5): 336.e1~336.e4 (IF=7.117)
[11]Yingying Su^(#); Guowei Ding; Kathleen H Reilly; Jessie L Norris; Huixin Liu; Zheng Li; Guixiang Wang; Ganggang Fang; Ning Wang^(*), Loss to follow-up and HIV incidence in female sex workers in Kaiyuan, Yunnan Province China: a nine year longitudinal study. BMC Infect Dis, 2016, 16(1): 526 (IF=2.565)
[12]Yingying Su^(#); Fujie Zhang; Huixin Liu; M Kumi Smith; Lin Zhu; Jing Wu; Ning Wang^(*), The prevalence of HIV-1 drug resistance among antiretroviral treatment naive individuals in mainland China: a meta-analysis. PLos One, 2014, 9(10): e110652 (IF=2.776)
[13]Yingying Su^(#); Jessie L Norris; Chunpeng Zang; Zhihang Peng; Ning Wang^(*), Incidence of hepatitis C virus infection in patients on hemodialysis: a systematic review and meta-analysis. Hemodial Int, 2013, 17(4): 532~541 (IF=1.737)
[14]Yingying Su^(#); Ruixue Yan; Zhongping Duan; Jessie L Norris; Lu Wang; Yan Jiang; Wenge Xing; Yu Chen; Yao Xiao; Lu Li; Jun Tao; Ning Wang^(*), Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing, China. J Med Virol, 2013, 85(3): 425~432 (IF=2.049)